Skip to main content
  • Contact
  • Glossary
  • Subscribe
  • Search

PATH's Malaria Vaccine Initiative

Accelerating Malaria Vaccine Development

  • Malaria, vaccines & biologics
    • Need for vaccines
      • Malaria vaccine roadmap
      • Preferred product characteristics
    • Malaria parasite life cycle
  • R&D and Introduction
    • First-generation vaccines
    • Next-generation vaccines
      • Pre-erythrocytic vaccine candidates
      • Blood-stage vaccine candidates
      • Transmission-blocking vaccine candidates
      • Combination vaccine candidates
    • Monoclonal antibodies
  • RTS,S
  • Access
    • Preparing for malaria vaccine decisions
      • Global policy and regulatory pathways
      • Decision-making framework
        • The decision-making framework for malaria vaccines
        • Economic analysis
        • Public health impact analysis
        • Sociocultural research
    • Financing
  • Resources
    • Search all resources
    • Fact sheets
    • Journal articles
    • Videos
    • Reports
    • Past projects
  • News
    • Press releases
    • Perspectives
  • About us
    • Donors
    • Contact us
  • Work with us
    • RFPs
    • Advocacy
      • Malaria Vaccine Advocacy Fellowship
      • Tools for advocates
    • Propose a project
  • Malaria, vaccines & biologics
    • Need for vaccines
      • Malaria vaccine roadmap
      • Preferred product characteristics
    • Malaria parasite life cycle
  • R&D and Introduction
    • First-generation vaccines
    • Next-generation vaccines
      • Pre-erythrocytic vaccine candidates
      • Blood-stage vaccine candidates
      • Transmission-blocking vaccine candidates
      • Combination vaccine candidates
    • Monoclonal antibodies
  • RTS,S
  • Access
    • Preparing for malaria vaccine decisions
      • Global policy and regulatory pathways
      • Decision-making framework
    • Financing
  • Resources
    • Search all resources
    • Fact sheets
    • Journal articles
    • Videos
    • Reports
    • Past projects
  • News
    • Press releases
    • Perspectives
  • About us
    • Donors
    • Contact us
  • Work with us
    • RFPs
    • Advocacy
      • Malaria Vaccine Advocacy Fellowship
      • Tools for advocates
    • Propose a project
  • Home
  • Resources
  • Fact sheets

Fact sheets

  • Frequently Asked Questions (FAQs): RTS,S/AS01 for seasonal use

    Published 25 Aug 2021
    Fact sheet
  • Frequently Asked Questions (FAQs): Product Transfer for the RTS,S/AS01 Malaria Vaccine

    Published 27 Jan 2021
    Fact sheet
  • The RTS,S malaria vaccine

    Published 17 Sep 2019
    Fact sheet
  • RTS,S malaria vaccine frequently asked questions (FAQs)

    Published 17 Sep 2019
    Fact sheet
  • RTS,S malaria vaccine implementation in Ghana

    Published 14 May 2019
    Fact sheet
  • RTS,S malaria vaccine implementation in Malawi

    Published 13 May 2019
    Fact sheet
  • PATH's Malaria Vaccine Initiative

    Published 13 Apr 2018
    Fact sheet
  • Preparing for malaria vaccines in Africa: A tool for malaria vaccine decision-making

    Published 24 Apr 2017
    Fact sheet
  • Researching and addressing community perceptions of vaccines and malaria

    Published 24 Apr 2017
    Fact sheet
  • Fighting malaria today and tomorrow

    Published 1 Jun 2016
    Fact sheet
  • Transmission-blocking vaccines (TBVs) against malaria

    Published 20 Apr 2016
    Fact sheet
  • Evaluation technologies – Generating reliable data for decision-making

    Published 20 Apr 2016
    Fact sheet

Pages

  • 1
  • 2
  • next ›
  • last »

PATH Washington DC

455 Massachusetts Avenue NW, Suite 1000

Washington, DC 20001 | USA 

Tel: 202.822.0033

Fax: 202.457.1466

Email: mvi_info [at] path.org

PATH Headquarters

2201 Westlake Avenue, Suite 200

Seattle, WA 98121 | USA 

Tel: 206.285.3500

Fax: 206.285.6619

Email: info [at] path.org

Website: www.path.org

Follow us

Mail
Twitter
  • Privacy policy
  • Copyright policy
  • Terms of use
© 2023 PATH
Website by Manta Ray Media